Absci reports Q2 GAAP EPS of -$0.21, missing estimates by $0.01

Seeking Alpha··US·Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Absci reported second-quarter 2026 financial results, posting a GAAP loss of $0.21 per share, missing analyst estimates by $0.01. Revenue came in at $0.3 million, down 50% year-over-year and falling short of expectations by $0.63 million. Cash, cash equivalents, and marketable securities totaled $201.1 million as of June 30, 2026, up from $125.7 million at the end of the prior quarter. Shares rose 4.44% following the release.

Impact on assets 1

Biotech & Genomic Medicine▼ · 1 stocks
Absci Corp
ABSI
▼ NegativeCapitalrelevance

Q2 GAAP EPS and revenue missed estimates, with revenue down 50% YoY.